Drugs.com - Pharma Industry News

GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM

THURSDAY, April 17, 2025 -- Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk for Alzheimer disease and related dementias (ADRDs) among people with...

Apr 17, 2025 - 18:58
 0
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
THURSDAY, April 17, 2025 -- Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk for Alzheimer disease and related dementias (ADRDs) among people with...
Read More

Tags:

Previous Article

Poor Communication Major Contributor to Patient Safety Incidents

Next Article

Twins Have Less Fat Accumulation Than Singletons Beginning in Early Pregnancy

Related Posts

Length of Stay After Lung Cancer Surgery Longer With Wildfire in County of Treating Facility

Length of Stay After Lung Cancer Surgery Longer With Wi...

Mar 14, 2025  0

Adolescent Perception of Weight Tied to Suicidal Ideation

Adolescent Perception of Weight Tied to Suicidal Ideation

Feb 20, 2025  0

Venous Thromboembolism Risk Higher for Certain Hormonal Contraceptives

Venous Thromboembolism Risk Higher for Certain Hormonal...

Feb 13, 2025  0